Vaccination

Featured

Vaccination has eradicated many of the world's most deadly infectious diseases and is used to prevent childhood diseases, highly contagious diseases such as COVID-19 and influenza, and viruses causing dangerous, chronic conditions such as hepatitis. Much of RAND's research on vaccination focuses on identifying barriers to immunization, determining strategies to promote vaccination, and studying the impact of vaccines on health in the United States and globally.

  • Vials with Pfizer-BioNTech and Moderna COVID-19 vaccine labels, March 19, 2021, photo by Dado Ruvic/Reuters

    Commentary

    Vaccine Patents Debate Risks Becoming a Sideshow

    May 17, 2021

    As COVID-19 cases continue to surge around the world, the debate is raging over whether patents on existing vaccines should be waived. But the global community could view patent waivers as just one of many available tools for speeding up vaccine delivery worldwide.

  • A health care worker from the El Paso Fire Department administers a COVID-19 vaccine at a vaccination center in El Paso, Texas, May 7, 2021, photo by Jose Luis Gonzalez/Reuters

    Commentary

    How Truth Decay Is Fueling Vaccine Hesitancy

    May 14, 2021

    A recent poll found that more than a quarter of Americans will not try to get vaccinated. The spread of misinformation and disinformation, which is rampant over social media, is one of the factors fueling vaccine hesitancy. And in turn, it's threatening our ability to end the pandemic for good.

Explore Vaccination

  • Blog

    Keeping COVID-19 Vaccines Moving, the Capitol Attack, Media Literacy: RAND Weekly Recap

    This weekly recap focuses on keeping COVID-19 vaccines moving to save more lives; why we need a national commission to investigate the U.S. Capitol attack; media literacy as a tool to counter “Truth Decay,” and more.

    Jan 22, 2021

  • Nurses prepare to vaccinate people at a drive-through COVID-19 vaccination site in Detroit, Michigan, January 15, 2021, photo by Emily Elconin/Reuters

    Commentary

    Keep the Vaccine Moving to Save the Most Lives

    The United States is waiting to be vaccinated against COVID-19 and millions of doses wait for arms. Policymakers at the national, state, and local levels have been stockpiling the shots for many reasons. While supply ramps up, policymakers could push to deliver vaccine to people instead of freezers.

    Jan 19, 2021

  • COVID-19 vaccine in a medical syringes at IU Health Bloomington, in Bloomington, Indiana, December 18, 2020, photo by Jeremy Hogan / SOPA Images/Sipa USA/Reuters

    Commentary

    Getting COVID-19 Vaccines to Pennsylvania Residents

    Pennsylvania state and county health departments have a number of options that could speed the delivery of COVID-19 vaccines to make sure Pennsylvania residents at high risk for severe COVID-19 outcomes are vaccinated as soon as possible.

    Jan 19, 2021

  • Blog

    Political Violence, COVID-19 Vaccine Questions, Mental Health Care: RAND Weekly Recap

    This weekly recap focuses on why we need to brace for more political violence after the Capitol attack, COVID-19 vaccine questions and answers, how to reform the U.S. mental health system, and more.

    Jan 15, 2021

  • COVID-19 vaccination stations inside Hillcrest High School, a designated New York City priority vaccination center for people in group 1B, in Queens, NY, January 11, 2021, photo by Anthony Behar/Reuters

    Commentary

    COVID-19 Options for 2021

    The disorganized public health response to the COVID-19 pandemic in the United States helped ensure that the nation led the world in infections nearly from the beginning of the pandemic. With vaccines now becoming available, are we over the problem? Not necessarily.

    Jan 12, 2021

  • The Moderna COVID-19 vaccine is administered during a drive through event at InclusivCare in Avondale, Louisiana, January 9, 2021 photo by Kathleen Flynn/Reuters

    Blog

    As the Vaccines Arrive, So Do the Questions

    As the first COVID-19 vaccines are being administered across the United States, countless questions have arisen about what comes next. Is one vaccine better than another? Can the United States both speed up inoculation and overcome some people's hesitance to get the shot? RAND experts offer insights into the historic vaccine rollout.

    Jan 11, 2021

  • Overcoming Hurdles to Herd Immunity (Teaser)

    Multimedia

    Overcoming Hurdles to Herd Immunity

    RAND senior physician policy researcher Mahshid Abir describes several hurdles to achieving herd immunity to COVID-19, including the politicization of the vaccine and the spread of misinformation.

    Jan 8, 2021

  • Periodical

    Periodical

    RAND Review: January-February 2021

    The cover story on the ’Internet of Bodies’ highlights the perils of devices that track personal health data and provide medical treatment. Other columns explore vaccine hesitancy, the high price of insulin in the U.S., and social justice in America.

    Jan 6, 2021

  • Chilean president Sebastián Piñera receives the first shipment of COVID-19 vaccines in Santiago de Chile, Chile, December 24, 2020, photo by Sebastian Rodríguez/Presidencia/Reuters

    Commentary

    Vaccine Nationalism Has Real Economic Consequences

    Vaccine nationalism, in which countries prioritize their domestic needs at the expense of others, will have significant global economic consequences. Major economies actually have more to gain by helping to make an effective COVID-19 vaccine widely available globally.

    Dec 30, 2020

  • Laura Bogart, photo by Diane Baldwin/RAND Corporation

    Q&A

    Medical Mistrust Could Reduce Vaccine Uptake: Q&A with Laura Bogart

    Laura Bogart, a senior behavioral scientist, studies how discrimination feeds medical mistrust and conspiracy beliefs. Her research on how mistrust became a barrier to treatment for Black Americans during the HIV epidemic sheds light on why some might question the safety of a COVID-19 vaccine.

    Dec 23, 2020

  • A man receives the first of two Pfizer/BioNTech COVID-19 shots, at Guy's Hospital in London, UK, December 8, 2020, photo by Victoria Jones/Pool/Reuters

    Commentary

    A Case for Vaccinating Teachers First

    Most agree that America's 18 million health care workers should top the list for COVID-19 vaccination. The 3.3 million teachers should come next. Vaccinating teachers could make it possible to open schools permanently and get parents back to work. That would help the economy recover.

    Dec 19, 2020

  • Blog

    Americans' Financial Struggles, COVID-19 Vaccinations, Virtual Schools: RAND Weekly Recap

    This weekly recap focuses on Americans' ongoing financial struggles, how we can learn from the first phase of COVID-19 vaccinations, why virtual schools may be here to stay, and more.

    Dec 18, 2020

  • Lynn Jones receives the COVID-19 vaccine at Jackson Madison County General Hospital in Jackson, Tennessee, Friday, Dec. 18, 2020, photo by Stephanie Amador/The Jackson Sun via Imagn Content Services, LLC/Reuters

    Commentary

    The Compensation System for Potential Side Effects Is an Important Part of a COVID-19 Vaccine Campaign

    Concern about potential COVID-19 vaccine side effects and their consequences may be contributing to Americans' reluctance to get vaccinated. Policymakers and the public should carefully consider what types and levels of compensation for any adverse effects of vaccination are truly fair and appropriate.

    Dec 18, 2020

  • Research Brief

    Research Brief

    The economic benefits of equitable global access to COVID-19 vaccines

    Researchers used a global macroeconomic model to examine the economic effects of vaccine nationalism. This brief highlights the cost to 30 high-income countries if low and middle-income countries miss out on initial access to COVID-19 vaccines.

    Dec 17, 2020

  • Healthcare workers take part in a rehearsal for the administration of the COVID-19 vaccine at Indiana University Health in Indianapolis, Indiana, December 11, 2020, photo by Bryan Woolston/Reuters

    Commentary

    COVID-19 Vaccination: Expect the Unexpected

    With emergency use authorization for the first COVID-19 vaccine now in place, states and localities have turned their focus to the logistics of dispensing it as quickly as feasible. Still, uncertainties abound. It is essential to build a process of learning into the plan.

    Dec 15, 2020

  • Blog

    Civic Education, 'Vaccine Nationalism,' Polar Icebreakers: RAND Weekly Recap

    This weekly recap focuses on how to revive civic education in America's public schools, the costs of "vaccine nationalism," why the United States needs more polar icebreaking ships, and more.

    Dec 11, 2020

  • Blog

    Restoring Public Trust, COVID-19 and Thanksgiving, Vaccinating Teachers: RAND Weekly Recap

    This weekly recap focuses on how the Biden-Harris administration can restore public trust, the risk of Thanksgiving becoming a super-spreader event, why teachers should be among the first to get a COVID19 vaccination, and more.

    Nov 25, 2020

  • A nurse prepares to inject a potential COVID-19 vaccine into a human patient, photo by PordeeStudio/Adobe Stock.

    Research Brief

    Unequal Access to COVID-19 Vaccines Would Further Damage the Global Economy

    As long as the coronavirus is not under control in all regions of the world there will continue to be a global economic cost associated with COVID-19. Vaccine nationalism could cost up to $1.2 trillion a year in GDP. If the poorest countries cannot access vaccines, the loss would be between $60 and $340 billion a year.

    Nov 5, 2020

  • Blog

    'Vaccine Nationalism,' a Pandemic Election, Women in the Workforce: RAND Weekly Recap

    This weekly recap focuses on why 'vaccine nationalism' could be costly, how Americans feel about voting during a pandemic, why women are leaving the workforce, and more.

    Oct 30, 2020

  • Vials of COVID-19 vaccine, photo by MarsBars/Getty Images

    Report

    COVID-19 'Vaccine Nationalism' Could Cost $1.2 Trillion a Year

    Nationalistic behavior by governments may exclude some countries from access to COVID-19 vaccines. This could cost the world economy up to $1.2 trillion a year in GDP. A globally coordinated effort to fight the pandemic is key, not only from a public health perspective but also an economic one.

    Oct 28, 2020

Research conducted by